TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 33 filers reported holding TELA BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,136 | -45.4% | 7,892 | -30.9% | 0.00% | – |
| Q2 2023 | $115,613 | -24.7% | 11,413 | -20.9% | 0.00% | – |
| Q1 2023 | $153,609 | +186.8% | 14,437 | +210.0% | 0.00% | – |
| Q4 2022 | $53,556 | – | 4,657 | +38708.3% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 12 | -94.2% | 0.00% | – |
| Q1 2022 | $2,000 | – | 206 | +488.6% | 0.00% | – |
| Q4 2021 | $0 | – | 35 | +6.1% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 33 | -99.5% | 0.00% | – |
| Q2 2021 | $109,000 | +3533.3% | 6,781 | +3256.9% | 0.00% | – |
| Q1 2021 | $3,000 | -96.2% | 202 | -96.1% | 0.00% | – |
| Q4 2020 | $78,000 | -27.8% | 5,162 | -21.1% | 0.00% | – |
| Q3 2020 | $108,000 | +260.0% | 6,544 | +182.4% | 0.00% | – |
| Q2 2020 | $30,000 | +1400.0% | 2,317 | +865.4% | 0.00% | – |
| Q1 2020 | $2,000 | – | 240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,475,293 | $22,188,000 | 5.76% |
| Opaleye Management Inc. | 365,000 | $5,490,000 | 0.72% |
| COWEN AND COMPANY, LLC | 401,776 | $6,043,000 | 0.54% |
| Orbimed Advisors | 3,027,542 | $45,534,000 | 0.40% |
| SANDERS MORRIS HARRIS LLC | 113,418 | $1,705,000 | 0.39% |
| RTW INVESTMENTS, LP | 1,383,816 | $20,813,000 | 0.35% |
| PURA VIDA INVESTMENTS, LLC | 309,323 | $4,652,000 | 0.17% |
| ARMISTICE CAPITAL, LLC | 256,000 | $3,850,000 | 0.13% |
| PERKINS CAPITAL MANAGEMENT INC | 11,000 | $165,000 | 0.11% |
| Rossmore Private Capital | 34,484 | $519,000 | 0.10% |